We recently published a list of 10 Unstoppable Stocks to Buy in 2025. In this article, we are going to take a look at where ...

We recently published a list of 35 Non-Tech AI Opportunities Amid DeepSeek Selloff. In this article, we are going to take a ...

Since markets tend to see a drop in volatility rather than a clear directional move, traders may find volatility-based strategies more effective than simple buy-or-sell approaches.

Weight-loss drugs are transforming health care and Wall Street, but exciting prospects don’t necessarily mean a company is a good investment.

Alterity Therapeutics ATHE shares moved upwards by 95.9% to $5.7 during Thursday's pre-market session. The market value of their outstanding shares is at $49.8 million. T ...

DeepSeek's AI model causes tech stocks to drop, but healthcare tech ETFs benefit from advancements in AI without vulnerability to market volatility.

We recently compiled a list of the Jim Cramer Discussed These 12 Stocks Amidst The DeepSeek AI Selloff. In this article, we are going to take a look at where UnitedHealth Group Incorporated ...

Cigna has deleveraged substantially after acquiring Express Scripts in late 2018 when Cigna's debt rose to over $42 billion, or debt/capital of 51%. Management has made good progress on its ...

While RFK Jr. is likely to lead the Department of HHS, he will be limited in his ability to stop the continued innovation and ...

WisdomTree U.S. SmallCap Dividend Fund offers a 2.8% yield but underperforms peers, with a sector allocation impacting growth potential. Learn more on DES stock here.

Driven by rapid innovations and the integration of modern technologies, the biotech sector is experiencing robust growth.